These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 20484567

  • 41. Glycosylation and immunoreactivity of the Histoplasma capsulatum Cfp4 yeast-phase exoantigen.
    Holbrook ED, Kemski MM, Richer SM, Wheat LJ, Rappleye CA.
    Infect Immun; 2014 Oct; 82(10):4414-25. PubMed ID: 25114108
    [Abstract] [Full Text] [Related]

  • 42. Protective efficacy of H antigen from Histoplasma capsulatum in a murine model of pulmonary histoplasmosis.
    Deepe GS, Gibbons R.
    Infect Immun; 2001 May; 69(5):3128-34. PubMed ID: 11292732
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Comparison of a new triazole, posaconazole, with itraconazole and amphotericin B for treatment of histoplasmosis following pulmonary challenge in immunocompromised mice.
    Connolly P, Wheat LJ, Schnizlein-Bick C, Durkin M, Kohler S, Smedema M, Goldberg J, Brizendine E, Loebenberg D.
    Antimicrob Agents Chemother; 2000 Oct; 44(10):2604-8. PubMed ID: 10991831
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Histoplasma capsulatum, lung infection and immunity.
    Horwath MC, Fecher RA, Deepe GS.
    Future Microbiol; 2015 Oct; 10(6):967-75. PubMed ID: 26059620
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. The HIF-1α/LC3-II Axis Impacts Fungal Immunity in Human Macrophages.
    Friedrich D, Zapf D, Lohse B, Fecher RA, Deepe GS, Rupp J.
    Infect Immun; 2019 Jul; 87(7):. PubMed ID: 31036602
    [Abstract] [Full Text] [Related]

  • 49. T cells require tumor necrosis factor-alpha to provide protective immunity in mice infected with Histoplasma capsulatum.
    Deepe GS, Gibbons RS.
    J Infect Dis; 2006 Jan 15; 193(2):322-30. PubMed ID: 16362898
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Galectin-3 negatively regulates dendritic cell production of IL-23/IL-17-axis cytokines in infection by Histoplasma capsulatum.
    Wu SY, Yu JS, Liu FT, Miaw SC, Wu-Hsieh BA.
    J Immunol; 2013 Apr 01; 190(7):3427-37. PubMed ID: 23455499
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Leukotriene B4-loaded microspheres as a new approach to enhance antimicrobial responses in Histoplasma capsulatum-infected mice.
    Nicolete R, Secatto A, Pereira PA, Soares EG, Faccioli LH.
    Int J Antimicrob Agents; 2009 Oct 01; 34(4):365-9. PubMed ID: 19604676
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Effect of Histoplasma capsulatum glucans on host innate immunity.
    Lara-Lemus R, Alvarado-Vásquez N, Zenteno E, Gorocica P.
    Rev Iberoam Micol; 2014 Oct 01; 31(1):76-80. PubMed ID: 24252831
    [Abstract] [Full Text] [Related]

  • 58. Diagnosis of disseminated histoplasmosis by detection of Histoplasma capsulatum antigen in serum and urine specimens.
    Wheat LJ, Kohler RB, Tewari RP.
    N Engl J Med; 1986 Jan 09; 314(2):83-8. PubMed ID: 3941695
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. The PD-1/PD-L costimulatory pathway critically affects host resistance to the pathogenic fungus Histoplasma capsulatum.
    Lázár-Molnár E, Gácser A, Freeman GJ, Almo SC, Nathenson SG, Nosanchuk JD.
    Proc Natl Acad Sci U S A; 2008 Feb 19; 105(7):2658-63. PubMed ID: 18268348
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.